Docking and binding mode analysis of aryl diketoacids (ADK) at the active site of HCV RNA-dependent RNA polymerase

Molecular Simulation

Volumn 32, Issue 14, 2006, Pages 1131-1138

  Kim, J ^a   Chong, Y ^a  

^a Konkuk University   (South Korea)

Author keywords

Aryl diketoacid (ADK); Docking; FlexX pharm; Hepatitis C virus (HCV); RNA dependent RNA polymerase

Indexed keywords

BINDING SITES; DOCKING; ENZYMES; HYDROPHOBICITY; RNA; SUBSTITUTION REACTIONS; VIRUSES;

AROMATIC RINGS; ARYL DIKETOACID (ADK); FLEXX-PHARM; HEPATITIS C VIRUS (HCV); RNA POLYMERASE;

ORGANIC ACIDS;

EID: 34548454840     PISSN: 08927022     EISSN: 10290435     Source Type: Journal    
DOI: 10.1080/08927020601007538     Document Type: Article

References (22)

1. H. Ago, T. Adashi, A. Yoshida, M. Yamamoto, N. Habuka, K. Yatsunami, M. Miyano. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Structure, 7, 1417 (1999).
2. S. Bressanelli, L. Tomei, F.A. Rey, R. De Francesco. Structural analysis of the hepatitis C virus RNA polymerase in complex with ribonucleotides. J. Virol., 76, 3482 (2002).
3. S. Bressanelli, L. Tomei, A. Roussel, I. Incitti, R.L. Vitale, M. Mathieu, R. De Francesco, F.A. Rey. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Proc. Natl. Acad. Sci. USA, 96, 13034 (1999).
4. C.A. Lesburg, M.B. Cable, E. Ferrari, Z. Hong, A.F. Mannarino, P.C. Weber. Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat. Struct. Biol., 6, 937 (1999).
5. L.J. Stuyver, T.R. McBrayer, T. Whitaker, P.M. Tharnish, M. Ramesh, S. Lostia, L. Cartee, J. Shi, A. Hobbs, R.F. Schinazi, K.A. Watanabe, M.J. Otto. Inhibition of the subgenomic hepatitis C virus replicon in huh-7 cells by 2′-deoxy-2′-fluorocytidine. Antimicrob. Agents Chemother., 48, 651 (2004).
6. L.J. Stuyver, T.R. McBrayer, P.M. Tharnish, A.E. Hassan, C.K. Chu, K.W. Pankiewicw, K.A. Watanabe, R.F. Schinazi, M.J. Otto. Dynamics of subgenomic hepatitis C virus replicon RNA levels in Huh-7 cells after exposure to nucleoside antimetabolites. J. Virol., 77, 10689 (2003).
7. A.B. Eldrup, C.R. Allerson, C.F. Bennett, S. Bera, B. Bhat, N. Bhat, M.R. Bosserman, J. Brooks, C. Burlein, S.S. Carroll, P.D. Cook, K.L. Getty, M. MacCoss, D.R. McMasters, D.B. Olsen, T.P. Prakash, M. Prhavc, Q. Song, J.E. Tomassini, J. Xia. Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase. J. Med. Chem., 47, 2283 (2004).
8. A.B. Eldrup, M. Prhavc, J. Brooks, B. Bhat, T.P. Prakash, Q. Song, S. Bera, N. Bhat, P. Dande, P.D. Cook, C.F. Bennett, S.S. Carroll, R.G. Ball, M. Bosserman, C. Burlein, L.F. Colwell, J.F. Fay, O.A. Flores, K. Getty, R.L. Lafemina, J. Leone, M. MacCoss, D.R. McMasters, J.E. Tomassini, D. VonLangen, B. Wolanski, D.B. Olsen. Structure-activity relationship of heterobase-modified 2′-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication. J. Med. Chem., 47, 5284 (2004).
9. J.LO. Clark, L. Hollecker, J.C. Mason, L.J. Stuyver, P.M. Tharnish, S. Lostia, T.R. McBrayer, R.F. Schinazi, K.A. Watanabe, M.J. Otto, P.A. Furman, W.J. Stec, S.E. Patterson, K.W. Pankiewicz. Design, synthesis, and antiviral activity of 2′-deoxy-2′-fluoro-2′-C-methyl-cytidine, a potent inhibitor of hepatitis C virus replication. J. Med. Chem., 48, 5504 (2005).
10. V. Summa, A. Petrocchi, P. Pace, V.G. Matassa, R. De Francesco, S. Altamura, L. Tomei, W. Koch, P. Neuner. Discovery of α, γ-diketo acids as potent selective and reversible inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase. J. Med. Chem., 47, 14 (2004).
11. J. Gästeiger, M. Marsili. Iterative partial equalization of orbital electronegativity - A rapid access to atomic charges. Tetrahedron, 36, 3219 (1980).
12. W.P. Purcell, J.A. Singer. A brief review and table of semiempirical parameters used in the Hückel molecular orbital method. J. Chem. Eng. Data., 12, 235 (1967).
13. J.M. Blaney, P.K. Weiner, A. Dearing, P.A. Kollman, E.C. Jorgensen, S.J. Oatley, J.M. Burridge, C.C.F. Blake. Molecular mechanics simulation of protein-ligand interactions: binding of thyroid hormone analogs to prealbumin. J. Am. Chem. Soc., 104, 6424 (1982).
14. G. Wipff, A. Dearing, P.K. Weiner, J.M. Blaney, P.A. Kollman. Molecular mechanics studies of enzyme-substrate interactions: the interaction of L- and D-N-acetyltryptophanamide with α-chymo-trypsin. J. Am. Chem. Soc., 105, 997 (1983).
15. K.M. Gilbert, W.J. Skawinski, M. Misra, K.A. Paris, N.H. Naik, R.A. Buono, H.M. Deutsch, C.A. Venanzi. Conformational analysis of methylphenidate: comparison of molecular orbital and molecular mechanics methods. J. Comput. Aided Mol. Des., 18, 719 (2004).
16. R. Di Santo, M. Fermeglia, M. Ferrone, M.S. Paneni, R. Costi, M. Artico, A. Roux, M. Gabriele, K.D. Tardif, A. Siddiqui, S. Pricl. Simple but highly effective three-dimensional chemical-feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA polymerase inhibitors. J. Med. Chem., 48, 6304 (2005).
17. S. Altamura, L. Tomei, U. Koch, P.J. Neuner, V. Summa. Diketoacid-derivatives as inhibitors of polymerases. PCT Int. Appl., WO 2000006529 (2000).
18. J.A. Grobler, K. Stillmock, B. Hu, M. Witmer, P. Felock, A.S. Espeseth, A. Wolfe, M. Egbertson, M, Bourgeois, J. Melamed. Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes. Proc. Natl. Acad. Sci. USA, 99, 6661 (2002).
19. G.C. Pais, X. Zhang, C. Marchand, N. Neamati, K. Cowansage, E.S. Svarovskaia, V.K. Pathak, Y. Tang, M. Nicklaus, Y. Pommier. Structure activity of 3-aryl-1, 3-diketo-containing compounds as HIV-1 integrase inhibitors. J. Med. Chem., 45, 3184 (2002).
20. S.A. Hindle, M. Rarey, C. Buning, T. Lengaue. Flexible docking under pharmacophore type constraints. J. Comput. Aided Mol. Des., 16, 129 (2002).
21. H. Huang, R. Chopra, G. Verdine, S.C. Harrison. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science, 282, 1669 (1998).
22. R. De Francesco, L. Tomei, S. Altamura, V. Summa, G. Migliaccio. Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. Antiviral Res., 58, 1 (2004).